Guy, J., Cheval, H., Selfridge, J. & Bird, A. The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 27, 631–652 (2011).

Article  CAS  PubMed  Google Scholar 

Chao, H. T. & Zoghbi, H. Y. MeCP2: only 100% will do. Nat. Neurosci. 15, 176–177 (2012).

Article  CAS  PubMed  Google Scholar 

Leonard, H., Cobb, S. & Downs, J. Clinical and biological progress over 50 years in Rett syndrome. Nat. Rev. Neurol. 13, 37–51 (2017).

Article  CAS  PubMed  Google Scholar 

Van Esch, H. et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77, 442–453 (2005).

Article  PubMed  PubMed Central  Google Scholar 

Lugtenberg, D. et al. Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy. Eur. J. Hum. Genet. 17, 444–453 (2009).

Article  CAS  PubMed  Google Scholar 

Takeguchi, R. et al. Early diagnosis of MECP2 duplication syndrome: insights from a nationwide survey in Japan. J. Neurol. Sci. 422, 117321 (2021).

Article  CAS  PubMed  Google Scholar 

Pascual-Alonso, A., Martinez-Monseny, A. F., Xiol, C. & Armstrong, J. MECP2-related disorders in males. Int. J. Mol. Sci. 22, 9610 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shahbazian, M. D. & Zoghbi, H. Y. Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am. J. Hum. Genet. 71, 1259–1272 (2002).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramocki, M. B. & Zoghbi, H. Y. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 455, 912–918 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nageshappa, S. et al. Altered neuronal network and rescue in a human MECP2 duplication model. Mol. Psychiatry 21, 178–188 (2016).

Article  CAS  PubMed  Google Scholar 

Marafi, D. et al. Spectrum and time course of epilepsy and the associated cognitive decline in MECP2 duplication syndrome. Neurology 92, e108–e114 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Ak, M. et al. Assessing the burden on caregivers of MECP2 duplication syndrome. Pediatr. Neurol. 133, 1–8 (2022).

Article  PubMed  Google Scholar 

Peters, S. U. et al. Phenotypic features in MECP2 duplication syndrome: effects of age. Am. J. Med. Genet. A 185, 362–369 (2021).

Article  CAS  PubMed  Google Scholar 

Shao, Y. et al. Antisense oligonucleotide therapy in a humanized mouse model of MECP2 duplication syndrome. Sci. Transl. Med. 13, eaaz7785 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sztainberg, Y. et al. Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides. Nature 528, 123–126 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu, B. et al. Reversal of social recognition deficit in adult mice with MECP2 duplication via normalization of MeCP2 in the medial prefrontal cortex. Neurosci. Bull. 36, 570–584 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu, C. et al. Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes. Nat. Methods 18, 499–506 (2021).

Article  CAS  PubMed  Google Scholar 

Kannan, S. et al. Compact RNA editors with small Cas13 proteins. Nat. Biotechnol. 40, 194–197 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Tong, H. et al. High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects. Nat. Biotechnol. 41, 108–119 (2023).

Article  CAS  PubMed  Google Scholar 

Pacheco, N. L. et al. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome. Mol. Autism 8, 56 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Brito, D. V. C., Gulmez Karaca, K., Kupke, J., Frank, L. & Oliveira, A. M. M. MeCP2 gates spatial learning-induced alternative splicing events in the mouse hippocampus. Mol. Brain 13, 156 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Renthal, W. et al. Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing. Nat. Neurosci. 21, 1670–1679 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gogliotti, R. G. et al. Total RNA sequencing of Rett syndrome autopsy samples identifies the M4 muscarinic receptor as a novel therapeutic target. J. Pharmacol. Exp. Ther. 365, 291–300 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heckman, L. D., Chahrour, M. H. & Zoghbi, H. Y. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice. eLife 3, e02676 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Collins, A. L. et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679–2689 (2004).

Article  CAS  PubMed  Google Scholar 

Ramocki, M. B., Tavyev, Y. J. & Peters, S. U. The MECP2 duplication syndrome. Am. J. Med. Genet. A 152A, 1079–1088 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224–1229 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morikawa, M., Derynck, R. & Miyazono, K. TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology. Cold Spring Harb. Perspect. Biol. 8, a021873 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Bajikar, S. S. et al. MeCP2 regulates Gdf11, a dosage-sensitive gene critical for neurological function. eLife 12, e83806 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).

Article